Relapsed melanoma
Showing 1 - 25 of 7,954
PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,
Not yet recruiting
- PD-1 Refractory Advanced Melanoma
- Responder-Derived Fecal microbiota transplantation (R-FMT
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Sep 1, 2023
Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)
Recruiting
- Metastatic Melanoma
- +9 more
- TBio-4101
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Melanoma (Skin), Melanoma, Uveal Trial in Oxford (Tebentafusp)
Recruiting
- Melanoma (Skin)
- Melanoma, Uveal
-
Oxford, United KingdomChurchill Hospital, Oxford University Hospitals NHS Trust
Jul 28, 2022
Melanoma Trial in Pittsburgh (Zimberelimab, Domvanalimab)
Recruiting
- Melanoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Apr 11, 2022
Melanoma, NSCLC, Colorectal Cancer Trial in United States (LYL845)
Recruiting
- Melanoma
- +2 more
- LYL845
-
Columbus, Ohio
- +3 more
Dec 19, 2022
Melanoma Trial in Fairway (tvs-CTL Vaccine)
Completed
- Melanoma
- tvs-CTL Vaccine
-
Fairway, KansasKU Cancer Center
Jan 20, 2022
NSCLC, Metastatic Colorectal Carcinoma, Refractory Melanoma Trial in Pittsburgh (Pixatimod, Nivolumab, Cyclophosphamide (low
Recruiting
- NSCLC
- +2 more
- Pixatimod
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 28, 2022
Head and Neck Squamous Cell Carcinoma, Melanoma, Cervical Cancer Trial in United States (RPTR-168)
Terminated
- Head and Neck Squamous Cell Carcinoma
- +2 more
- RPTR-168
-
Scottsdale, Arizona
- +3 more
Dec 2, 2022
Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)
Recruiting
- Melanoma
- +4 more
- Pembrolizumab
-
Aurora, Colorado
- +18 more
Jan 5, 2023
Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)
Recruiting
- Osteosarcoma
- +9 more
- Cryoablation Therapy
- +2 more
-
Washington, District of ColumbiaChildren's National Hospital
Mar 21, 2022
Relapsed Neuroblastoma, Refractory Neuroblastoma, Relapsed Osteosarcoma Trial in Houston (C7R-GD2.CART cells, Cyclophosphamide,
Recruiting
- Relapsed Neuroblastoma
- +6 more
- C7R-GD2.CART cells
- +2 more
-
Houston, Texas
- +1 more
Nov 12, 2021
AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United
Recruiting
- AIDS-Related Non-Hodgkin Lymphoma
- +29 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Birmingham, Alabama
- +12 more
Aug 4, 2022
Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma Trial in Worldwide (BNT111, Cemiplimab)
Recruiting
- Melanoma Stage III
- +2 more
- BNT111
- Cemiplimab
-
Tucson, Arizona
- +53 more
Aug 24, 2022
Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)
Recruiting
- Head and Neck Cancer
- +6 more
- Recombinant L-IFN adenovirus injection
-
Shanghai, Shanghai, ChinaShanghai Fengxian District Central Hospital
Jan 16, 2022
Cancer, Solid Tumor, Melanoma Trial in United States (ST-067)
Recruiting
- Cancer
- +7 more
- ST-067
-
Scottsdale, Arizona
- +3 more
Mar 21, 2022
Melanoma Trial in Los Angeles (dendritic cell-MART-1 peptide vaccine, leukapheresis)
Completed
- Melanoma
- dendritic cell-MART-1 peptide vaccine
- leukapheresis
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020
Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Tumor Trial in Houston
Recruiting
- Recurrent Cutaneous Melanoma
- +27 more
- Cord Blood-derived Expanded Allogeneic Natural Killer Cells
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 28, 2021
Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers
Recruiting
- Ocular Sebaceous Carcinoma
- +5 more
- Sentinel Lymph Node Biopsy
-
Roma, Rome, ItalyGustavo Savino
Apr 3, 2023
Breast Cancer, Lung Cancer, Melanoma Trial in Nashville (1-methyl-D-tryptophan)
Terminated
- Breast Cancer
- +4 more
-
Nashville, TennesseeVanderbilt University
May 26, 2020
Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor Trial in Memphis (drug, biological, device)
Completed
- Ewing Sarcoma
- +12 more
- alemtuzumab
- +6 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 14, 2020
Sarcoma, Melanoma, NSCLC Trial in United States (CMB305, G100, Metronomic CPA)
Terminated
- Sarcoma
- +3 more
- CMB305
- +2 more
-
Santa Monica, California
- +7 more
Jun 29, 2020